Literature DB >> 23476015

Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.

Huilan Lin1, JoAnn Trejo.   

Abstract

Thrombin cleaves the N terminus of PAR1, generating a new N-terminal domain that functions as a tethered ligand that binds intermolecularly to activate PAR2 in trans. The mechanisms that regulate PAR1-PAR2 heterodimer signaling and trafficking are not known. We now report that PAR1 and PAR2 form a heterodimer that exhibits unique trafficking and signaling behaviors compared with receptor protomers. Using bioluminescence resonance energy transfer, immunofluorescence microscopy, co-immunoprecipitation, and cells expressing receptors exogenously and endogenously, we show that PAR1 and PAR2 specifically interact and form stable dimers. Intriguingly, the PAR1-PAR2 heterodimer displays constitutive internalization that is driven by PAR1 C-terminal tail sorting motifs and is a process that enhances dimer formation. Upon thrombin activation, PAR1-PAR2 dimers co-internalize and recruit β-arrestins to endosomes. Remarkably, PAR1-PAR2 heterodimers appear to utilize a distinct interface for β-arrestin interaction compared with receptor protomers. Moreover, thrombin-activated PAR1-PAR2 heterodimers enhance β-arrestin-mediated ERK1/2 activation in the cytoplasm, whereas activated ERK1/2 induced by the thrombin-activated PAR1 protomer redistributes to the nucleus. Thus, the formation of PAR1-PAR2 heterodimers provides additional modes of thrombin-stimulated signaling responses that appear to be distinctly regulated compared with the receptor protomer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23476015      PMCID: PMC3630854          DOI: 10.1074/jbc.M112.439950

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.

Authors:  G Cristina Brailoiu; Tudor I Oprea; Pingwei Zhao; Mary E Abood; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

3.  Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.

Authors:  P J O'Brien; N Prevost; M Molino; M K Hollinger; M J Woolkalis; D S Woulfe; L F Brass
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

Review 4.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

5.  PAR3 is a cofactor for PAR4 activation by thrombin.

Authors:  M Nakanishi-Matsui; Y W Zheng; D J Sulciner; E J Weiss; M J Ludeman; S R Coughlin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 6.  Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.

Authors:  Eric Reiter; Seungkirl Ahn; Arun K Shukla; Robert J Lefkowitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-09-19       Impact factor: 13.820

7.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

8.  ALIX binds a YPX(3)L motif of the GPCR PAR1 and mediates ubiquitin-independent ESCRT-III/MVB sorting.

Authors:  Michael R Dores; Buxin Chen; Huilan Lin; Unice J K Soh; May M Paing; William A Montagne; Timo Meerloo; JoAnn Trejo
Journal:  J Cell Biol       Date:  2012-04-30       Impact factor: 10.539

9.  Structure of the human κ-opioid receptor in complex with JDTic.

Authors:  Huixian Wu; Daniel Wacker; Mauro Mileni; Vsevolod Katritch; Gye Won Han; Eyal Vardy; Wei Liu; Aaron A Thompson; Xi-Ping Huang; F Ivy Carroll; S Wayne Mascarella; Richard B Westkaemper; Philip D Mosier; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

10.  beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.

Authors:  K A DeFea; J Zalevsky; M S Thoma; O Déry; R D Mullins; N W Bunnett
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  42 in total

1.  Heterodimerization with Its splice variant blocks the ghrelin receptor 1a in a non-signaling conformation: a study with a purified heterodimer assembled into lipid discs.

Authors:  Sophie Mary; Jean-Alain Fehrentz; Marjorie Damian; Gérald Gaibelet; Hélène Orcel; Pascal Verdié; Bernard Mouillac; Jean Martinez; Jacky Marie; Jean-Louis Banères
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

2.  Regulation of protease-activated receptor 1 signaling by the adaptor protein complex 2 and R4 subfamily of regulator of G protein signaling proteins.

Authors:  Buxin Chen; David P Siderovski; Richard R Neubig; Mark A Lawson; Joann Trejo
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

3.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

4.  Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Authors:  Mohammad Jaber; Miriam Maoz; Arun Kancharla; Daniel Agranovich; Tamar Peretz; Sorina Grisaru-Granovsky; Beatrice Uziely; Rachel Bar-Shavit
Journal:  Cell Mol Life Sci       Date:  2013-11-01       Impact factor: 9.261

Review 5.  G Protein-Coupled Receptor Heteromers.

Authors:  Ivone Gomes; Mohammed Akli Ayoub; Wakako Fujita; Werner C Jaeger; Kevin D G Pfleger; Lakshmi A Devi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

Review 6.  Protease-activated receptors in hemostasis.

Authors:  Marvin T Nieman
Journal:  Blood       Date:  2016-04-28       Impact factor: 22.113

7.  N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling bias.

Authors:  Antonio G Soto; Thomas H Smith; Buxin Chen; Supriyo Bhattacharya; Isabel Canto Cordova; Terry Kenakin; Nagarajan Vaidehi; JoAnn Trejo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

8.  Protease-activated receptor-4 and purinergic receptor P2Y12 dimerize, co-internalize, and activate Akt signaling via endosomal recruitment of β-arrestin.

Authors:  Thomas H Smith; Julia G Li; Michael R Dores; JoAnn Trejo
Journal:  J Biol Chem       Date:  2017-06-26       Impact factor: 5.157

Review 9.  Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.

Authors:  Nisha R Pawar; Marguerite S Buzza; Toni M Antalis
Journal:  Cancer Res       Date:  2019-01-04       Impact factor: 12.701

10.  The physical association of the P2Y12 receptor with PAR4 regulates arrestin-mediated Akt activation.

Authors:  Aasma Khan; Dongjun Li; Salam Ibrahim; Emer Smyth; Donna S Woulfe
Journal:  Mol Pharmacol       Date:  2014-04-10       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.